• Contact
Tuesday, July 29, 2025
  • Login
Oklahoma Business Voice
  • Home
  • News
    • All
    • Aerospace
    • Childcare
    • Education
    • Energy & Environment
    • Federal
    • Film & Television Industry
    • Finance
    • Health Care
    • Innovation
    • Issues Affecting Oklahomans
    • OBV One-on-One
    • Opinion
    • Politics & Elections
    • Taxes & Budget
    • Tribal
    • Workforce Development
    State Suppliers Expo in Oklahoma

    Suppliers Expo to bring Oklahoma businesses, state agencies together

    Happy Diverse School Children And Teacher Woman Having Class Sitting At Desk In Classroom At School. Modern Education And Knowledge Concept. Selective Focus

    Rogers State University targets Oklahoma’s elementary teacher shortage

    Photo from Ascension St. John

    Tulsa’s Ascension St. John hospital now Level I trauma center

    Oklahoma City Skyline

    Oklahoma City residents to vote on $2.7 billion bond program

  • Sign UpNEW
  • About
  • Contact
  • Advertise With Us!
No Result
View All Result
  • Home
  • News
    • All
    • Aerospace
    • Childcare
    • Education
    • Energy & Environment
    • Federal
    • Film & Television Industry
    • Finance
    • Health Care
    • Innovation
    • Issues Affecting Oklahomans
    • OBV One-on-One
    • Opinion
    • Politics & Elections
    • Taxes & Budget
    • Tribal
    • Workforce Development
    State Suppliers Expo in Oklahoma

    Suppliers Expo to bring Oklahoma businesses, state agencies together

    Happy Diverse School Children And Teacher Woman Having Class Sitting At Desk In Classroom At School. Modern Education And Knowledge Concept. Selective Focus

    Rogers State University targets Oklahoma’s elementary teacher shortage

    Photo from Ascension St. John

    Tulsa’s Ascension St. John hospital now Level I trauma center

    Oklahoma City Skyline

    Oklahoma City residents to vote on $2.7 billion bond program

  • Sign UpNEW
  • About
  • Contact
  • Advertise With Us!
No Result
View All Result
Oklahoma Business Voice
No Result
View All Result
Home News
Mountain View, California - April 26, 2018: A logo sign outside of the headquarters of 23andMe. The company is an American personal genomics and biotechnology company based in Mountain View, California

Oklahoma attorney general joins DNA lawsuit against 23andMe

Hicham Raache by Hicham Raache
June 16, 2025
in News
Reading Time: 3 mins read
Share on FacebookShare on Twitter

OKLAHOMA CITY (OBV) – Oklahoma Attorney General Gentner Drummond signed onto a bipartisan, multistate lawsuit filed in federal court to block 23andMe from selling millions of customers’ private DNA information without their permission.

Drummond and attorneys general from 27 other states filed the lawsuit to protect the genetic data of 23andMe’s approximately 15 million customers.

23andMe, a human genetics and biotechnology company, filed for bankruptcy in March. The attorneys general contend the company’s plan to auction off customers’ genetic data as part of its bankruptcy proceedings violates consumer protection laws.

“Oklahomans trusted 23andMe with their most personal information, and now the company wants to sell that data to the highest bidder without even asking permission,” Drummond said. “This isn’t just another business asset that can be auctioned off. This is deeply personal genetic information that could affect not just customers, but their children and grandchildren for generations to come. We’re taking legal action to ensure that Oklahomans maintain control over their own genetic data.” 

23andMe was founded in 2006. It became well-known for providing customers insight into their ethnic ancestry through DNA analysis. Customers sent 23andMe saliva-based DNA samples in company-provided kits. The company analyzed each DNA sample and provided a genetic breakdown of the customer’s ethnic heritage. The company also participated in health research and drug development.

NPR reported that 23andMe struggled to stay profitable after going public in 2021. It laid off 40 percent of its staff and filed for Chapter 11 bankruptcy protection in the Eastern District of Missouri in March, causing concern over customer data privacy.

The lawsuit filed by the attorneys general seeks to guarantee the right of 23andMe customers to control such personal information and prevent it from being sold like ordinary property. It looks to ensure the genetic data is not misused, exposed in future data breaches or used in ways customers did not anticipate, according to officials from Drummond’s office.

Biological samples, DNA data, health-related traits and medical records are too sensitive to be sold without customers’ express, informed consent, according to the lawsuit.

23andMe Holding Co. officials announced in May that the company will be purchased for $256 million by Regeneron Pharmaceuticals, Inc., a biotechnology company that invents, develops and commercializes medicines to treat serious diseases.

Regeneron’s purchase includes all of 23andMe’s assets, including the Personal Genome Service (PGS), Total Health and Research Services business lines.

23andMe representatives say they are committed to protecting sensitive customer data.

“We required anyone bidding for 23andMe to agree to comply with our privacy policies and all applicable privacy laws. This means that Regeneron has agreed that it will process your customer personal data in accordance with the 23andMe consents, privacy policies and statements, terms of service, and notices currently in effect and have security controls in place designed to protect such data,” company representatives said in a statement in May. “Regeneron will comply with applicable laws by providing updated privacy notices when it changes how it uses your data and obtain your consent if required under applicable laws.”

Tags: 23andMeAttorney General Gentner DrummondAttorneys GeneralBankruptcyBiological SamplesBiotechnology CompanyChapter 11ConsentCustomer DataCustomersData BreachData PrivacyDNA AnalysisDNA DataDNA InformationDrug DevelopmentEastern District of MissouriEthnic AncestryEthnic HeritageGenetic AnalysisGenetic DataGenetic InformationHealth ResearchHealth-Related TratesLawsuitMedical RecordsMultistate LawsuitOklahomaPermissionPersonal Genome ServicePGSPrivatePrivate InformationRegeneron Pharmaceuticals Inc.Research ServicesTotal Health
ShareTweetShare
Previous Post

Gov. Stitt signs bill to create Oklahoma business courts

Next Post

Oklahoma Commerce touts record job growth, legislative wins

Related Posts

State Suppliers Expo in Oklahoma
News

Suppliers Expo to bring Oklahoma businesses, state agencies together

July 29, 2025
Happy Diverse School Children And Teacher Woman Having Class Sitting At Desk In Classroom At School. Modern Education And Knowledge Concept. Selective Focus
Education

Rogers State University targets Oklahoma’s elementary teacher shortage

July 25, 2025
Photo from Ascension St. John
News

Tulsa’s Ascension St. John hospital now Level I trauma center

July 24, 2025
Oklahoma City Skyline
News

Oklahoma City residents to vote on $2.7 billion bond program

July 24, 2025
Gov. Kevin Stitt said a focused workforce management system is needed in Oklahoma to attract top companies to the state.
News

Gov. Stitt lauds Oklahoma revenue growth, low unemployment

July 21, 2025
School lunch being served to students
Education

Oklahoma State Dept. of Education mandates free lunches for students

July 18, 2025
Next Post
Photo courtesy of Oklahoma Department of Commerce

Oklahoma Commerce touts record job growth, legislative wins

Oklahoma Business Voice

© 2023 Oklahoma State Chamber.
Powered by High Five Media.
Privacy Policy

Navigate Site

  • Home
  • News
  • Sign Up
  • About
  • Contact
  • Advertise With Us!

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
  • Sign Up
  • About
  • Contact
  • Advertise With Us!

© 2023 Oklahoma State Chamber.
Powered by High Five Media.
Privacy Policy

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.